Assessing iron overload: Are we there yet?
| dc.contributor.author | Kruger, P. | |
| dc.contributor.author | Leahy, M. | |
| dc.contributor.author | Olynyk, John | |
| dc.date.accessioned | 2017-01-30T10:30:31Z | |
| dc.date.available | 2017-01-30T10:30:31Z | |
| dc.date.created | 2013-03-21T20:00:56Z | |
| dc.date.issued | 2012 | |
| dc.identifier.citation | Kruger, Paul C. and Leahy, Michael F. and Olynyk, John K. 2012. Assessing iron overload: Are we there yet?. Clinical Cancer Research. 18 (23): pp. 6395-6397. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/3347 | |
| dc.identifier.doi | 10.1158/1078-0432.CCR-12-2881 | |
| dc.description.abstract |
Iron overload occurs in many hematologic disorders and causes significant morbidity. The advantages of MRI in quantifying liver iron concentration continue to mount, and the association between iron overload and increased mortality after allogeneic stem cell transplant needs further attention. | |
| dc.publisher | American Association Cancer Research | |
| dc.title | Assessing iron overload: Are we there yet? | |
| dc.type | Journal Article | |
| dcterms.source.volume | 1 | |
| dcterms.source.startPage | 6395 | |
| dcterms.source.endPage | 6397 | |
| dcterms.source.issn | 10780432 | |
| dcterms.source.title | Clinical Cancer Research | |
| curtin.note |
Copyright © 2012 American Association for Cancer Research | |
| curtin.department | ||
| curtin.accessStatus | Open access |